New England Journal of MedicineThe New England Journal of Medicine (NEJM) RSS feed -- current issue. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practicePERSPECTIVE: Donating Hearts after Cardiac Death -- Reversing the Irreversible- August 13, 2008 In this issue of the Journal, Boucek et al. (pages 709-714) report on three cases of heart transplantation from infants who were pronounced dead on the basis of cardiac criteria. ...http://content.nejm.org/cgi/content/short/359/7/672?rss=1&query=current CME: Naltrexone for the Management of Alcohol Dependence- August 13, 2008 (No abstract is available for this citation)http://cme.nejm.org/cgi/cme/nejmcme_course;NJ200808143590727?rss=1&query=current PERSPECTIVE: The Dead Donor Rule and Organ Transplantation- August 13, 2008 In this issue of the Journal, Boucek et al. (pages 709-714) report on three cases of heart transplantation from infants who were pronounced dead on the basis of cardiac criteria. ...http://content.nejm.org/cgi/content/short/359/7/674?rss=1&query=current ORIGINAL ARTICLE: Brief Report: Pediatric Heart Transplantation after Declaration of Cardiocirculatory Death- August 13, 2008 This report describes transplantation of hearts from three infant donors (mean age at donation, 3.7 days) who had died from cardiocirculatory causes. The recipients (mean age, 2.2 months) all survived to 6 months with excellent left ventricular function. This approach to transplantation has been controversial but offers the prospect of expanding the donor pool. <P>http://content.nejm.org/cgi/content/short/359/7/709?rss=1&query=current ORIGINAL ARTICLE: Effect of PCI on Quality of Life in Patients with Stable Coronary Disease- August 13, 2008 In the COURAGE trial, percutaneous coronary intervention (PCI), added to optimal medical therapy, did not reduce the subsequent rate of death or myocardial infarction among patients with chronic coronary disease. A quality-of-life analysis showed that measures of health status improved significantly with either strategy, but patients in the PCI group had greater initial improvements. <P>http://content.nejm.org/cgi/content/short/359/7/677?rss=1&query=current CLINICAL THERAPEUTICS: Naltrexone for the Management of Alcohol Dependence- August 13, 2008 A 44-year-old businessman presents with clinical evidence of alcohol dependence and acknowledges excessive drinking. The use of naltrexone is recommended. Naltrexone is an opioid-blocking agent that inhibits reward signaling in the brain and reduces alcohol craving. Hepatotoxicity has been reported with naltrexone. This drug should not be used in patients who are physically dependent on opiates. <P>http://content.nejm.org/cgi/content/short/359/7/715?rss=1&query=current ORIGINAL ARTICLE: Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention- August 13, 2008 Bivalirudin is a new direct thrombin inhibitor. In patients undergoing PCI for stable coronary disease, bivalirudin and unfractionated heparin resulted in similar overall outcomes, but there was less major bleeding with bivalirudin. <P>http://content.nejm.org/cgi/content/short/359/7/688?rss=1&query=current CME: Effect of PCI on Quality of Life in Patients with Stable Coronary Disease- August 13, 2008 (No abstract is available for this citation)http://cme.nejm.org/cgi/cme/nejmcme_course;NJ200808143590729?rss=1&query=current |